SRW Nrv1 Focus Brain Health Supplement for Focus Alertness and Cognitive Support

EMIS+ Verified independent store

→

Quick answer: SRW Nrv1 Focus Brain Health Supplement for Focus Alertness and Cognitive Support is available in Singapore from EMIS+ (emis.asia), a nurse-led medical and wellness su pplier offering genuine stock and fast local delivery. See the details and FAQs below, and consult a healthcare professional for advice specific to your needs. Clinical Summary: SRW Nrv1 Focus is a brain health supplement formulated by Science Research Wellness (New Zealand) to support cognitive function, focus, and alertness through a multi-mechanism approach targeting neuronal protein homeostasis, neurotransmitter balance, and neuroplasticity. The formula incorporates Percepta (containing PTI-00703 cat's claw extract, Uncaria tomentosa), which has been studied for its ability to inhibit tau protein aggregation and amyloid-beta fibril formation — two pathological processes associated with age-related cognitive decline. Additional botanical actives including Bacopa monnieri, Hericium erinaceus (lion's mane), and GABA precursors support acetylcholine synthesis, nerve growth factor (NGF) stimulation, and synaptic plasticity. Available in Singapore from EMIS+ at SGD $106 per 60-capsule bottle. Product Overview Nrv1 Focus addresses cognitive health through two primary biological pathways. The first involves neural protein quality control: PTI-00703, a standardised alkaloid-rich extract of Uncaria tomentosa (cat's claw), has been shown in peer-reviewed studies to inhibit the aggregation of tau filaments and amyloid-beta (Aβ) peptides — the protein aggregates implicated in neurodegenerative decline. By supporting the clearance and prevention of these aggregates, PTI-00703 aims to preserve the structural integrity of neural circuits involved in memory and executive function. The Percepta proprietary blend encapsulates these alkaloids for consistent dosing and bioavailability. The second pathway focuses on neurotransmitter support and neuroplasticity. Bacopa monnieri (brahmi) has been evaluated in randomised controlled trials for improving speed of visual information processing, learning rate, and memory consolidation in healthy adults, mediated in part through acetylcholinesterase inhibition and BDNF upregulation. Hericium erinaceus (lion's mane mushroom) contains hericenones and erinacines that cross the blood-brain barrier and stimulate nerve growth factor (NGF) synthesis — critical for the maintenance and regeneration of cholinergic neurons. Together, these ingredients form a complement of neuroprotective, neuroplastic, and neurotransmitter-supportive mechanisms relevant to both high-demand cognitive performance and long-term brain health maintenance. Specifications Manufacturer Science Research Wellness (SRW), New Zealand Product Name SRW Nrv¹ Focus Key Ingredient 1 Percepta / PTI-00703 — Uncaria tomentosa (cat's claw) alkaloid extract; tau aggregation and Aβ fibril inhibition Key Ingredient 2 Bacopa monnieri (brahmi) — standardised bacosides; acetylcholinesterase inhibition, BDNF support Key Ingredient 3 Hericium erinaceus (lion's mane) — hericenones and erinacines; NGF synthesis stimulation Additional Actives MemorTea blend; GABA precursors; supporting neurotransmitter balance and stress resilience Formulation Capsule (vegetarian) Pack Size 60 capsules per bottle; SGD $106 (compare-at SGD $215) Storage Below 25°C, away from direct light and moisture; keep out of reach of children Manufacturing Standard GMP (Good Manufacturing Practice) certified facility, New Zealand Regulatory Dietary supplement; complies with Singapore Food Regulations and Health Products Act; TGA-aligned manufacturing Suitable For Adults 18+; consult physician before use during pregnancy, breastfeeding, or if taking neurological medications Key Applications Supporting sustained focus, working memory, and mental clarity in students, professionals, and knowledge workers with high cognitive demands Neuroprotective supplementation for adults over 40 seeking to maintain brain health and attenuate age-related cognitive decline, including mild memory lapses and processing speed reduction Adjunct support alongside lifestyle interventions (exercise, sleep optimisation, dietary modification) in early-stage cognitive health management Neuroplasticity and NGF support in individuals recovering from neurological stress, burnout, or post-viral cognitive symptoms Longevity and preventive brain health protocols in functional medicine and healthy-aging programmes in Singapore Frequently Asked Questions Q: What is PTI-00703 and how does it relate to brain health?A: PTI-00703 is a proprietary alkaloid-rich extract derived from Uncaria tomentosa (cat's claw bark). Published laboratory studies (Snow et al., J Ethnopharmacol; Castillo-Lanes et al.) demonstrate that specific alkaloids from this plant inhibit the in vitro aggregation of tau protein filaments and amyloid-beta (Aβ) peptides — pathological aggregates associated with neurodegenerative conditions. PTI-00703 forms the core of the Percepta blend used in Nrv1 Focus. Q: Is there clinical evidence that Bacopa monnieri improves memory in healthy adults?A: Yes. Multiple randomised, double-blind, placebo-controlled trials in healthy adults have demonstrated significant improvements in delayed word recall, speed of information processing, and working memory after 12 weeks of standardised Bacopa supplementation (Morgan & Stevens, J Altern Complement Med 2010; Stough et al., Psychopharmacol 2001). Benefits are typically observed after 8–12 weeks of consistent use. Q: Can Nrv1 Focus be taken alongside prescription medications for cognitive or neurological conditions?A: Bacopa monnieri may have mild acetylcholinesterase inhibitory activity; caution is warranted if co-administering cholinesterase inhibitors (e.g. donepezil, rivastigmine). GABA-active ingredients may potentiate sedative medications. Consult your Singapore-registered neurologist or GP before combining Nrv1 Focus with any prescription neurological, psychiatric, or sedative medications. Q: How long before cognitive benefits from Nrv1 Focus are noticed?A: Based on clinical evidence for constituent ingredients, cognitive improvements from Bacopa monnieri are typically measurable at 8–12 weeks. Lion's mane NGF stimulation studies show effects at 4–8 weeks in some trials. PTI-00703 neuroprotective mechanisms are primarily preventive and long-term. Consistent daily use is required; individual responses vary by age, baseline cognitive status, and lifestyle factors. Q: Where can I purchase SRW Nrv1 Focus in Singapore and is it HSA-registered?A: SRW Nrv1 Focus is available from EMIS+ at emis.asia with islandwide Singapore delivery. As a dietary supplement, it falls under Singapore Food Regulations rather than the HSA Therapeutic Products Register. EMIS+ imports the product through lawful channels compliant with the Health Sciences Authority (HSA) Health Products Act. Bulk institutional orders are available — contact EMIS+ at emis.asia. {"@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [{"@type": "Question", "name": "What is PTI-00703 and how does it relate to brain health?", "acceptedAnswer": {"@type": "Answer", "text": "PTI-00703 is a proprietary alkaloid-rich extract derived from Uncaria tomentosa (cat's claw bark). Published laboratory studies (Snow et al., J Ethnopharmacol; Castillo-Lanes et al.) demonstrate that specific alkaloids from this plant inhibit the in vitro aggregation of tau protein filaments and amyloid-beta (Aβ) peptides — pathological aggregates associated with neurodegenerative conditions. PTI-00703 forms the core of the Percepta blend used in Nrv1 Focus."}}, {"@type": "Question", "name": "Is there clinical evidence that Bacopa monnieri improves memory in healthy adults?", "acceptedAnswer": {"@type": "Answer", "text": "Yes. Multiple randomised, double-blind, placebo-controlled trials in healthy adults have demonstrated significant improvements in delayed word recall, speed of information processing, and working memory after 12 weeks of standardised Bacopa supplementation (Morgan & Stevens, J Altern Complement Med 2010; Stough et al., Psychopharmacol 2001). Benefits are typically observed after 8–12 weeks of consistent use."}}, {"@type": "Question", "name": "Can Nrv1 Focus be taken alongside prescription medications for cognitive or neurological conditions?", "acceptedAnswer": {"@type": "Answer", "text": "Bacopa monnieri may have mild acetylcholinesterase inhibitory activity; caution is warranted if co-administering cholinesterase inhibitors (e.g. donepezil, rivastigmine). GABA-active ingredients may potentiate sedative medications. Consult your Singapore-registered neurologist or GP before combining Nrv1 Focus with any prescription neurological, psychiatric, or sedative medications."}}, {"@type": "Question", "name": "How long before cognitive benefits from Nrv1 Focus are noticed?", "acceptedAnswer": {"@type": "Answer", "text": "Based on clinical evidence for constituent ingredients, cognitive improvements from Bacopa monnieri are typically measurable at 8–12 weeks. Lion's mane NGF stimulation studies show effects at 4–8 weeks in some trials. PTI-00703 neuroprotective mechanisms are primarily preventive and long-term. Consistent daily use is required; individual responses vary by age, baseline cognitive status, and lifestyle factors."}}, {"@type": "Question", "name": "Where can I purchase SRW Nrv1 Focus in Singapore and is it HSA-registered?", "acceptedAnswer": {"@type": "Answer", "text": "SRW Nrv1 Focus is available from EMIS+ at emis.asia with islandwide Singapore delivery. As a dietary supplement, it falls under Singapore Food Regulations rather than the HSA Therapeutic Products Register. EMIS+ imports the product through lawful channels compliant with the Health Sciences Authority (HSA) Health Products Act. Bulk institutional orders are available — contact EMIS+ at emis.asia."}}]} Show more